It healthily contributes to the bountiful life creation with Melsmon
I aim at the elite company based on the international perspective.
In that tissue therapy Institute continue to study the usefulness of tissue therapy, in order to try to spread the placenta and medical production by hydrolysis of human placenta preparation, reorganized in 1956, was founded.
We will do our best to be to pursue the study of the usefulness and effectiveness of further, as a corporate group that can contribute to society, come out with a safe drug.
Representative Director Koichiro Funyu